L Babini
-
- Lymphoma Diagnosis and Treatment 16
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 6
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 4
-
- Sarcoma Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 4
-
- Viral-associated cancers and disorders 4
-
- Bone Tumor Diagnosis and Treatments 4
L Babini
33 papers receiving 449 citations
Peers
Comparison fields: 5 of 35
- Pathology and Forensic Medicine 253
- Neurology 149
- Genetics 82
- Otorhinolaryngology 29
- Hematology 67
Countries citing papers authored by L Babini
This map shows the geographic impact of L Babini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Babini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Babini more than expected).
Fields of papers citing papers by L Babini
This network shows the impact of papers produced by L Babini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Babini. The network helps show where L Babini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L Babini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2001 | 4 | |
| 3 | 2001 | 6 | |
| 4 | Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia. | 2001 | 9 |
| 5 | 2000 | 9 | |
| 6 | 1999 | 65 | |
| 7 | 1999 | 8 | |
| 8 | 1999 | 13 | |
| 9 | 1996 | 26 | |
| 10 | 1996 | 26 | |
| 11 | 1996 | 1 | |
| 12 | 1995 | 10 | |
| 13 | Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease. | 1994 | 25 |
| 14 | 1994 | 6 | |
| 15 | 1994 | 1 | |
| 16 | 1994 | 7 | |
| 17 | 1992 | 16 | |
| 18 | 1992 | 8 | |
| 19 | 1990 | 56 | |
| 20 | 1984 | 47 |
About L Babini
L Babini is a scholar working on Otorhinolaryngology, Pathology and Forensic Medicine, Oncology, Genetics and Neurology, having authored 33 papers that have together received 464 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Sarcoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers), Head and Neck Cancer Studies (4 papers), Bone Tumor Diagnosis and Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (253 citations), Neurology (149 citations), Genetics (82 citations), Otorhinolaryngology (29 citations) and Hematology (67 citations). L Babini has collaborated with scholars based in Italy, United States and Belarus. Frequent co-authors include Elena Barbieri, S Tura, Pier Luigi Zinzani, Filíppo Gherlinzoni, Ermanno Emiliani, Giovanni Frezza, G. Frezza, Stefano Neri, Massimo Magagnoli and Maurizio Bendandi. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Stem Cells, Gene, British Journal of Haematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.